RMAM
NVAX icon

Raab & Moskowitz Asset Management’s Novavax NVAX Stock Holding History

Raab & Moskowitz Asset Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-50
Closed -$6K – 296
2014
Q4 		$6K Buy
+50
New +$5.22K ﹤0.01% 385

Other funds holding NVAX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Raab & Moskowitz Asset Management's NVAX Position: Q1 2015 in Review

Raab & Moskowitz Asset Management sold out of Novavax (NVAX) in Q1 2015, closing a stake of 50 shares — an estimated $6K sold.

Raab & Moskowitz Asset Management first reported a position in NVAX in Q4 2014 and held it in 1 quarter. The position peaked at $6K in Q4 2014. 167 funds tracked by Wall St. Rank hold NVAX as of Q1 2015.

  • Raab & Moskowitz Asset Management reported no remaining Novavax position as of Q1 2015 after selling out during the quarter.
  • Raab & Moskowitz Asset Management sold 50 Novavax shares in Q1 2015, an estimated $6K.
  • Raab & Moskowitz Asset Management first reported a position in Novavax in Q4 2014 and held it in 1 quarter.
  • Raab & Moskowitz Asset Management's Novavax position peaked at $6K in Q4 2014.
  • 167 funds tracked by Wall St. Rank held Novavax as of Q1 2015.

Based on Raab & Moskowitz Asset Management's 13F filing for Q1 2015, filed 12 May 2015.